SCHEMBL2371400

SCHEMBL2371400

Cc1ccc2nc3ccc(C)cc3cc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.62
NQO2 P16083 1/20 0.58
NCK1 P16333 1/20 0.58
BACE1 P56817 1/20 0.58
CYP2A6 P11509 3/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
PSMB5 P28074 2/20 0.53
ALDH1A1 P00352 3/20 0.52
PDE3B Q13370 2/20 0.50
PDE3A Q14432 2/20 0.50
MAPT P10636 3/20 0.47
MITF O75030 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PDE2A O00408 1/20 0.47
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9755319 0.91 CYP1A2 (0.65) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL4427125 0.89 NQO2 (0.65) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL862247 0.89 CYP1A2 (0.52) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL19242781 0.87 KDM4E (0.57) CYP1A2NQO2NCK1BACE1MEN1
SCHEMBL12965819 0.83 CYP1A2 (0.47) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL11702937 0.82 LMNA (0.67) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL862359 0.80 MEN1 (0.56) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL2756741 0.80 NQO2 (0.85) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL9927345 0.80 NQO2 (0.85) CYP1A2NQO2NCK1BACE1CYP2A6
SCHEMBL13072350 0.79 CYP1A2 (0.52) CYP1A2NQO2NCK1BACE1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0747701-B1 Micelle protection assay GEN PROBE INC (US) 2001-12-05 EP claimed
US-12043749-B2 Method for producing ink composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-07-23 US disclosed
US-12043749-B2 Method for producing ink composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-07-23 US disclosed
US-11917839-B2 High signal-to-noise ratio photoelectric conversion element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-02-27 US disclosed
US-11917839-B2 High signal-to-noise ratio photoelectric conversion element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-02-27 US disclosed
US-20240023422-A1 COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-18 US disclosed
US-20240023422-A1 COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-18 US disclosed
US-11877459-B2 Light detecting element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-16 US disclosed
US-11877459-B2 Light detecting element SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-16 US disclosed
WO-2023238764-A1 COMPOSITION, FILM, ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND PHOTODETECTION ELEMENT 住友化学株式会社 2023-12-14 WO disclosed
EP-2311893-A1 COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME Sumitomo Chemical Company, Limited (JP) 2011-04-20 EP disclosed
US-20110004102-A1 ORGANIC PIEZOELECTRIC MATERIAL, ULTRASONIC OSCILLATOR USING THE SAME, METHOD FOR PRODUCING THE ULTRASONIC OSCILLATOR, ULTRASONIC PROBE AND ULTRASONIC MEDICAL DIAGNOSTIC IMAGING DEVICE KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-01-06 US disclosed
US-7662478-B2 Polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-16 US disclosed
US-20090054649-A1 Bridged Organosilane and Production Method Thereof KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-02-26 US disclosed
US-20090054649-A1 Bridged Organosilane and Production Method Thereof KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-02-26 US disclosed
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED 2008-05-01 US disclosed
US-20080073618-A1 Light energy conversion material KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2008-03-27 US disclosed
US-20080073618-A1 Light energy conversion material KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2008-03-27 US disclosed
EP-1894628-A2 Light energy conversion material comprising donor-acceptor substituted poylsiloxanes Kabushiki Kaisha Toyota Chuo Kenkyusho (JP) 2008-03-05 EP disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME CRY1, ARCN1, CORO1A CYP1A2 2208/4885NQO2 3440/4885NCK1 4218/4885
US-20090054649-A1 Bridged Organosilane and Production Method Thereof C5, CCNE1, QSOX1 CYP1A2 218/4885NQO2 1166/4885NCK1 3161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.